Akros

Akros Pharma is a clinical-stage pharmaceutical company based in Princeton, New Jersey, serving as the primary clinical development arm for Japan Tobacco Inc. (JT) and Torii Pharmaceutical in the United States and Europe. The company focuses on advancing a diverse pipeline of small molecules through clinical trials, primarily targeting nephrology, immunology, and metabolic diseases. Notable programs in their portfolio include enarodustat for renal anemia and delgocitinib for atopic dermatitis. By leveraging the research and development capabilities of its parent organization, Akros Pharma manages clinical trial design, regulatory submissions, and monitoring to bring innovative therapies to global markets. The company plays a critical role in bridging Japanese pharmaceutical innovation with Western clinical and regulatory standards.